Abstract
HaemophiliaVolume 28, Issue 5 p. e145-e148 LETTER TO THE EDITOR Immune checkpoint inhibitor-induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system Donald C. Moore, Corresponding Author Donald C. Moore Donald.moore1@atriumhealth.org orcid.org/0000-0001-5629-9505 Atrium Health, Department of Pharmacy, Levine Cancer Institute, Charlotte, North Carolina, USA Correspondence Donald C. Moore, Atrium Health, Department of Pharmacy, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA. Email: Donald.moore1@atriumhealth.orgSearch for more papers by this authorJoseph B. Elmes, Joseph B. Elmes Atrium Health, Department of Pharmacy, Levine Cancer Institute, Concord, North Carolina, USASearch for more papers by this authorJustin R. Arnall, Justin R. Arnall orcid.org/0000-0003-0901-4866 Atrium Health, Specialty Pharmacy Service, Charlotte, North Carolina, USASearch for more papers by this authorScott A. Strassels, Scott A. Strassels Department of Pharmacy, Atrium Health, Charlotte, North Carolina, USASearch for more papers by this authorJai N. Patel, Jai N. Patel Atrium Health, Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Charlotte, North Carolina, USASearch for more papers by this author Donald C. Moore, Corresponding Author Donald C. Moore Donald.moore1@atriumhealth.org orcid.org/0000-0001-5629-9505 Atrium Health, Department of Pharmacy, Levine Cancer Institute, Charlotte, North Carolina, USA Correspondence Donald C. Moore, Atrium Health, Department of Pharmacy, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA. Email: Donald.moore1@atriumhealth.orgSearch for more papers by this authorJoseph B. Elmes, Joseph B. Elmes Atrium Health, Department of Pharmacy, Levine Cancer Institute, Concord, North Carolina, USASearch for more papers by this authorJustin R. Arnall, Justin R. Arnall orcid.org/0000-0003-0901-4866 Atrium Health, Specialty Pharmacy Service, Charlotte, North Carolina, USASearch for more papers by this authorScott A. Strassels, Scott A. Strassels Department of Pharmacy, Atrium Health, Charlotte, North Carolina, USASearch for more papers by this authorJai N. Patel, Jai N. Patel Atrium Health, Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Charlotte, North Carolina, USASearch for more papers by this author First published: 27 July 2022 https://doi.org/10.1111/hae.14632Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume28, Issue5September 2022Pages e145-e148 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Haemophilia : the official journal of the World Federation of Hemophilia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
